2021-03-05 Bayer Cropscience Ltd. Prabhudas Lilladhar

5164.20 6022.00 5164.20
(7.32%) Target met Accumulate 2021-02-12 Bayer Cropscience Ltd. Prabhudas Lilladhar

5201.00 6022.00 5201.00
(6.56%) Target met Accumulate

Q3FY21 Result Update - Giving away the gains of hay days (1H) - Downgrade to Accumulate

We downgrade BYRCS topline/EBITDA/APAT estimates by 1%/9%/9% for FY21, 1%/4%/5% for FY22 and 1%/7%/8% for FY23. We roll over to FY23 estimates and maintain Accumulate rating with revised target price of Rs 6022 (Previous TP 6090) based on 35x FY23 EPS of Rs 172. Bayer reported disappointing results. While topline was in-line with our estimates @ Rs 9.2 bn with 8% growth (PLe Rs 9.3 bn), gross margin contracted by sharp 542 bps due to lower sales of high margin corn seeds and product repositioning...

2020-11-10 Bayer Cropscience Ltd. Prabhudas Lilladhar

 

5101.05 6090.00 5101.05
(8.65%) Target met Accumulate

Q2FY21 Result Update - Soft quarter, Downgrade to Accumulate

We lower BYRCSs topline, EBITDA & APAT estimates by 2%/3%/3% for FY21E, 3%/7%/6% for FY22E & 4%/5%/5% for FY23E to factor in lower topline growth and reduced gross margin expansion than earlier anticipated. We downgrade the stock to ACCUMULATE (from BUY) with revised TP of Rs 6090 (Previous 6421) based on 35x Sept22 EPS of Rs 167. We continue to like the stock due to its lean business model, robust cash flow generation and superior return ratios of ~20-25%. BYRCSs 3% topline growth was largely...

2020-08-07 Bayer Cropscience Ltd. Prabhudas Lilladhar

6057.30 6421.00 6057.30
(-8.50%) Target met Buy

Q1FY21 Result Update - Good all-round performance - BUY

Bayer reported better than expected results with robust growth in both crop protection and seeds segment. Topline/EBITDA/APAT grew by 29%/61%/57% YoY. Gross margin contraction of 240 bps would have been largely due to higher sales growth of Roundup (Glyphosate) which is a low margin product for the company. Liquidation growth continues to be better than placement growth implying limited build-up of stocks at the dealer level. With robust paddy plantings and decent growth in Corn acreages, seeds segment is...

2020-06-04 Bayer Cropscience Ltd. Prabhudas Lilladhar 5392.20 6010.00 5392.20
(2.79%) Target met Buy

Channel Check Update - Industry set for +20% growth in 1QFY21

Domestic agrochemical industry is expected to grow +20% YoY in Q1 driven by massive surge in herbicide sales, pre-buying led by robust demand expectation and ~5% price increase in generic molecules. Geographically, North India followed by South is expected to drive growth. Also, crop wise Rice will be the single largest growth driver for the industry driven by acreage expansion and shift from transplanting rice to Direct Seeded Rice (DSR). Molecules like Bispyribac Sodium (Key player PI Ind- Nominee Gold), Pyrazosulfuron (UPL- Saathi, Dhanuka- Cempa) Pendimethalin (UPL- Dost...

2020-05-24 Bayer Cropscience Ltd. Prabhudas Lilladhar

5334.75 6010.00 5334.75
(3.89%) Target met Buy

Q4FY20 Result Update - COVID Shadow looms large; Reduce

BYRCS reported solid results, topline grew by 82% YoY driven by high corn portfolio sales and sharp growth in CP segment. Massive sales return in 4QFY19 (57% revenue decline in 4QFY19 for core-BYRCS) led to favourable base but even excluding that growth is expected to be ~15-20% in CP. EBITDA (Rs582mn) and APAT (Rs601mn) reversed into profits from losses last year....

2020-05-04 Bayer Cropscience Ltd. Ashika Research 4623.45 5425.00 4623.45
(19.88%) Target met Buy
2020-03-12 Bayer Cropscience Ltd. Prabhudas Lilladhar

 

4001.20 5288.00 4001.20
(38.52%) Target met Buy 2019-05-31 Bayer Cropscience Ltd. Prabhudas Lilladhar 3815.15 3783.00 3815.15
(45.27%) Target met Hold

Q4FY19 Result Update

BYRCS reported disappointing 4Q results with high costs and decline in Change in Estimates | Target | Reco revenue of ~57% YoY (due high sales return) leading to EBITDA and PAT loss. Subdued market conditions led to sales return of placed stocks (even though...

2019-02-05 Bayer Cropscience Ltd. Emkay

4324.95 4840.00 4324.95
(28.15%) Target met Sell

Bayer CropScience reported 29% yoy revenue growth to Rs6.2bn in Q3FY19, which was above o...

Bayer CropScience reported 29% yoy revenue growth to Rs6.2bn in Q3FY19, which was above our and consensus estimates. Despite overall domestic remaining under stress the performance was driven by rice, fruits and vegetable segments. Gross margins improved by 130bps yoy to 42% owing to better product mix and inventory gains. EBITDA margin expanded 280bps yoy to 7.5% vs. our estimates of 5.7%....

2018-10-23 Bayer Cropscience Ltd. Emkay

 

4210.00 3743.00 4210.00
(31.65%) Target met Sell

Bayer reported a revenue decline of 10% yoy to Rs11.0bn, which was well below our and ...

Bayer reported a revenue decline of 10% yoy to Rs11.0bn, which was well below our and consensus estimates, primarily due to adverse weather conditions in India (uneven rainfall and hailstorms) which affected standing crops, leading to down-trading by farmers. Despite this, gross margins improved by 170bps yoy to 39.9% on better product mix and inventory gains. However, EBITDA margins contracted by 350bps yoy due to a lower...

2017-11-09 Bayer Cropscience Ltd. HDFC Securities 3899.95 3899.95
(42.11%) Results Update

Bayer CropScience Ltd Q2FY18 results comment

Bayer CropScience Ltd Q2FY18 results comment Revenue grew by 76.5% to Rs. 1232.0 Cr in Q2FY18 when compared to the previous quarter. Also, it increased by 11.61% when compared with Q2FY17.

2017-08-14 Bayer Cropscience Ltd. Axis Direct 4266.45 4200.00 4266.45
(29.91%) Target met Hold

Result Update - Bayer CropScience

Weak Q1 with revenue down by 15% (flat expected) and PAT at Rs 1.1 bn (Rs 1.4 bn expected). EBITDA margin plummeted to 16.6% (~23% in Q1FY17). The domestic business (~85% of revenue) was impacted by GST-led destocking, while international business was affected by weak global agrichem market.

2017-06-08 Bayer Cropscience Ltd. Axis Direct

4700.85 4200.00 4700.85
(17.90%) Target met Hold

Result Update:Bayer Crop Sci.

Past buy-back: In the past, Bayer has done two buybacks of Rs 5 bn each (~46% of prevailing cash)at 7%-18%/4%-11% premium to 3M/2WVWAP.

2017-05-29 Bayer Cropscience Ltd. HDFC Securities 4415.50 4415.50
(25.52%) Results Update 2017-05-24 Bayer Cropscience Ltd. Emkay

4445.20 4625.00 4445.20
(24.68%) Target met Hold

Bayer reported a sharp 50% yoy drop in revenues to Rs2.4bn and below our estimate of ...

Bayer reported a sharp 50% yoy drop in revenues to Rs2.4bn and below our estimate of Rs4.7bn (after adjusting for Ind-AS) and is also below consensus estimates. Revenue was impacted due to weak season in South India which constitutes 65% of Q4 sales Gross margins improved 430bps yoy to 44.6% benefiting from lower RM cost. However, Company reported EBITDA loss of Rs581mn vs. a profit of Rs 205mn in Q4FY16 Loss at...

2017-02-17 Bayer Cropscience Ltd. Axis Direct 4008.00 4050.00 4008.00
(38.28%) Target met Hold

Visit Note:Bayer Crop Sci.

Bayers management expects CY17 to be a challenging year due to lower reservoir levels, high channel inventories and poor farmer liquidity;however, firm commodity prices and one goodagri-seasonare sufficient to address these issues. Despite challenges, Bayers domestic revenue grew 16% YoY in 9M..

2015-09-24 Bayer Cropscience Ltd. Karvy 3722.75 3322.00 3722.75
(48.88%) Target met Sell

Bayer Cropscience Ltd: Return of Capital to Shareholders the Major Trigger (Sep 24, 2015)

Increasing proportion of manufactured goods in the overall revenue from 43%in FY15 to 44% in FY17E is expected to lead to a 20 basis points jump in grossmargins from 64.8% in FY15 to 65.0% in FY16E & FY17E. It could have been higher, if not for the weak macro-industry environment. This increase is expected to act as a cushion for the EBITDA margins going forward. But, significant dependence on traded goods will continue to act as a ceiling for margins. We expect EBITDA margins to remain stable at lower levels of 11.9% & 12.3% in FY16E & FY17E respectively.

Reach out

Find us at the office

Gieser- Madigan street no. 4, 89728 Tokyo, Japan

Give us a ring

Danyelle Malanche
+96 551 917 434
Mon - Fri, 10:00-17:00

Tell us about you